Seeking Alpha

candooman

candooman
Send Message
View as an RSS Feed
View candooman's Comments BY TICKER:
Latest comments  |  Highest rated
  • Sirius XM +1.3%, adds $2B in buyback authorization, to total $8B [View news story]
    SIRI is taking advantage of the very low interest available today before the FED raises the interest rate, to buy back shares at today's relatively low prices. Bottom line is SIRI saves a lot of money by borrowing instead of using their cash on hand. A couple of years from now, when the interest rates are much higher, SIRI will then pay off its loans with cash on hand.
    Aug 26, 2015. 04:50 PM | 2 Likes Like |Link to Comment
  • Why I Think InVivo Shares Are Worth A Double [View article]
    We have hundreds of thousands of people who had accidents over many decades that fit the NVIV criteria. They did not get any treatment (noe available until now) and the results are all on record. No need to have new controls.
    Aug 20, 2015. 03:43 PM | 1 Like Like |Link to Comment
  • Why I Think InVivo Shares Are Worth A Double [View article]
    #3 got treated today. Sept 30 we will know his progress.
    Aug 20, 2015. 03:38 PM | Likes Like |Link to Comment
  • A Case For Ocata Therapeutics [View article]
    Where did you get your information on the OCATA trials from? Looks like you did not do proper due diligence or did not understand the past results of the trials. Coming from an Opthalmologist..... if I had a problem with my eyes, I assure you, I will not come to you for treatment.
    Aug 20, 2015. 02:47 AM | 1 Like Like |Link to Comment
  • Ocata Therapeutics: Insider Enrichment, Failed Science, Long History Of Fraud Ties, 77% Downside [View article]
    To be able to borrow money, a company has to show it can pay it back. OCAT got the money today ($7 Million) so the lender is confident OCAT is a viable company!
    Aug 19, 2015. 01:41 PM | 7 Likes Like |Link to Comment
  • Ocata Therapeutics: Insider Enrichment, Failed Science, Long History Of Fraud Ties, 77% Downside [View article]
    It appears that the author's intent in writing this article is to bring down OCAT. I think most investors who have read this piece have seen this, hence, the share is up 6%.
    Aug 19, 2015. 01:33 PM | 11 Likes Like |Link to Comment
  • Ocata Therapeutics: Insider Enrichment, Failed Science, Long History Of Fraud Ties, 77% Downside [View article]
    Furthermore. the author has shown his selective use of information to support his arguments. He ignores the fact that OCAT's CEO had explained at the last two Quarterly Conference Calls, that the upcoming Ph 2 Trials will have Blind (no pun intended) Placebo patients - half will get the treatment, the other half will get a placebo treatment only. ( I feel bad that these people's eyes will continue to deteriorate and have zero chance of seeing better unless the trial is so successful, they will be given the treatment too, and hopefully by then it is not too late.) Then some will get immune suppressants and some will not to determine if it is needed or not.
    Aug 19, 2015. 01:29 PM | 9 Likes Like |Link to Comment
  • Ocata Therapeutics: Insider Enrichment, Failed Science, Long History Of Fraud Ties, 77% Downside [View article]
    This article is full of false information.

    Start with trial record of 12 months monitoring only.
    The first patient was injected with 50,000 cell dosage in 2010.... more than 5 years ago and no evidence of tumor or cell turning into bones or other type of cells. First patient was so successful the she wants her "control" eye to be treated too but to date, OCAT refuses.

    "This is not a typo: There were only 4 patients in the study."
    42 patients have been treated as of last year in the Ph 1/2a Trial.

    There are more falsehoods.... this is so bad I do not know why I am even making comments here and just wasting my time and raising my blood pressure.
    Aug 19, 2015. 01:02 PM | 23 Likes Like |Link to Comment
  • A Case For Ocata Therapeutics [View article]
    OCAT just announced this morning that they raised $10 funding. No mention of selling securities (dilution). But they just sold $30million, what is going on? JMY - what does this men, more dilution,
    Aug 19, 2015. 09:43 AM | Likes Like |Link to Comment
  • OK, I'll Say It: Sirius XM Had A Great Quarter [View article]
    The article 'Why I Sold Sirius XM After Earnings for Zero Gain' main theme was that AT&T was getting into the connected car business big time and was therefore going to wipe out SIRI XM. A reader commented that the argument had a serious flaw because that connected car business was a collaboration between AT&T and SIRI and provided a link to a long article that discussed at length the joint venture. For some reason Seeking Alpha took out those comments.
    Aug 17, 2015. 01:08 PM | 4 Likes Like |Link to Comment
  • OK, I'll Say It: Sirius XM Had A Great Quarter [View article]
    SIRI has a lock on the radio band spectrum and there is no spectrum available, hence no one will be launching a satellite.
    Aug 17, 2015. 12:56 PM | 2 Likes Like |Link to Comment
  • Sirius XM: Please Tell Me Again About The Big Bad Connected Car [View article]
    Yup, too far away. When that time comes, SIRI would have used up ALL its losses and have to pay taxes on its earnings so that will be another ball game.
    Aug 17, 2015. 08:33 AM | Likes Like |Link to Comment
  • Sirius XM: Please Tell Me Again About The Big Bad Connected Car [View article]
    Woooah! Hold your horses Don! Cable and Satellite are losing customers in part, because of their bundling policies. They are now correcting this problem by offering cheaper ala carte plans. However, their coverage of live events are keeping them alive and well. Siri's live coverage is helping keep subscribers as well. Any time there is a special event, SIRI usually offers it. This, Pandora and the other music only businesses cannot match. Now that the season of Political debates have started, I am sure SIRI will cover them as well. I am not a subscriber (I drive about 300 miles a year only) so I do not know if they covered the GOP debate which was a blockbuster!
    Aug 17, 2015. 08:28 AM | Likes Like |Link to Comment
  • Ocata Therapeutics' (OCAT) CEO Paul Wotton on Q2 2015 Results - Earnings Call Transcript [View article]
    All these positives you mentioned is not worth anything if the Ph2 trials keep getting moving into the 'promise of the future'. The science is settled. The trials are just for verification using a different placebo. So why the long delay?
    Aug 11, 2015. 01:56 AM | Likes Like |Link to Comment
  • MagicJack VocalTec up 11.7% on Q2 profit beat [View news story]
    Good performance but not much future growth with all that competition on VOIP.

    Share price will not move very much in the future.
    Aug 11, 2015. 01:42 AM | Likes Like |Link to Comment
COMMENTS STATS
379 Comments
622 Likes